Takeda Pharmaceutical Company Financial Overview
Takeda Pharmaceutical Company's market cap is currently $49.30B. The company's EPS TTM is $-0.025; its P/E ratio is 184.82; and it has a dividend yield of 3.86%. Takeda Pharmaceutical Company is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $0.17. See an overview of income statement, balance sheet, and cash flow financials.
